Results 51 to 60 of about 12,826 (224)

What Happens After Menopause (WHAM)? A Progress Report of a Prospective Controlled Study of Women After Pre‐Menopausal Risk‐Reducing Bilateral Salpingo‐Oophorectomy

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Surgical menopause, the removal of both ovaries prior to natural menopause, may impact short‐and long‐term physical and emotional health. An increasingly common cause of surgical menopause is risk‐reducing salpingo‐oophorectomy (RRSO) in those at high inherited risk of ovarian cancer.
Sarah A. L. Price   +12 more
wiley   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel   +5 more
wiley   +1 more source

Comparison of MHT and PDA track initiation performance

open access: yes, 2008
The relative performance of multiple hypothesis tracking (MHT) and probabilistic data association (PDA) track initiation is investigated using simulated wide-area-surveillance radar data. The scenarios involve single targets that are low-observable (i.e.
Kennedy, H.L., Hugh L. Kennedy
core   +1 more source

Resolution of the Vi International Forum of Experts on Menopausal Hormone Therapy

open access: yesРепродуктивная эндокринология
On November 27, 2024, the VI International Forum of Experts on Menopausal Hormone Therapy (MHT) was held with the support of the Ukrainian Association of Gynecologists-Endocrinologists.
F.A. Gafurova   +6 more
doaj   +1 more source

The beneficial effects of menopausal hormone therapy on renal survival in postmenopausal Korean women from a nationwide health survey

open access: yesScientific Reports, 2021
Several studies have demonstrated the nephroprotective effects of estrogen on renal damage. In light of the inconsistent results of previous findings, this study aims to evaluate the in-depth role of menopausal hormone therapy (MHT) on the development of
Shin Young Ahn   +5 more
doaj   +1 more source

Modern Management of the Menopause: Are We Measuring What Matters?

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Assess uptake of the Core Outcomes in Menopause (COMMA) core outcome sets (COS) and examine whether frontline treatments for vasomotor and genitourinary symptoms have been evaluated against these key outcomes. Design Methodological review. Setting Published literature and international clinical trial registries.
Joscelyn Gan   +7 more
wiley   +1 more source

Effect modification analysis; interaction of MHT use with age.

open access: yes, 2018
Effect modification analysis; interaction of MHT use with age.
Nicholas C. Harvey (454379)   +14 more
core   +1 more source

Multiple hypothesis testing (MHT) of average donations (comparison between the control and emotion treatments).

open access: yes, 2021
Multiple hypothesis testing (MHT) of average donations (comparison between the control and emotion treatments).
Lisette Ibanez (11506671)   +1 more
core   +1 more source

Evaluation of Modified Hodge Test as a Non-molecular Assay for Accurate Detection of KPC-producing Klebsiella pneumoniae [PDF]

open access: yesPolish Journal of Microbiology, 2018
Klebsiella pneumoniae carbapenemase (KPC) have become a major therapeutic challenge because of its increasingly fast dissemination throughout the world. Accurate detection of KPC is essential for optimal treatment.
ATOSSA GHASEMNEJAD   +2 more
doaj   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy